Data demonstrates the strength of Werewolf’s innovative therapeutic approach across multiple conditionally activated pipeline programsCAMBRIDGE, Mass., Dec. 01, 2021 (GLOBE…
-DISSOLVE program on track with 12-month study fully enrolled--DISSOLVE II on track for full enrollment in early 2022--Top-line data from…
Giant Eagle guests now have access to free hearing screenings from InnerScope's Automated Self-Check Hearing Screening Kiosks located in select…
RENO, Nev., Dec. 01, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing…
Prescription Drug User Fee Act (PDUFA) Target Action Date of March 25, 2022EMERYVILLE, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) --…
Dr. Colin brings four decades of clinical experience in pediatric pulmonology to Beyond Air, with research spanning respiratory physiology, Cystic…
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company…
Company to host virtual investor event on Sunday, December 12, 2021 at 11:00 a.m. ETSOUTH SAN FRANCISCO, Calif., Dec. 01,…
NEW YORK, NY, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),…
Former Chief Medical Officer of Juno Therapeutics Brings Decades of Oncology Clinical Development ExpertiseNEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE)…